Haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy vs other donor transplantations in adults with hematologic cancers: a …
N Gagelmann, A Bacigalupo, A Rambaldi… - JAMA …, 2019 - jamanetwork.com
Importance Use of haploidentical (HAPLO) stem cell transplantation with posttransplant
cyclophosphamide is rapidly increasing in adults with hematologic cancers. However, its …
cyclophosphamide is rapidly increasing in adults with hematologic cancers. However, its …
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide
SR McCurdy, L Luznik - Hematology 2014, the American …, 2019 - ashpublications.org
HLA-haploidentical hematopoietic stem cell transplantation is now one of the most
commonly employed alternative donor techniques, with most centers applying T-cell–replete …
commonly employed alternative donor techniques, with most centers applying T-cell–replete …
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
MJ Wieduwilt, L Metheny III, MJ Zhang… - Blood …, 2022 - ashpublications.org
The role of haploidentical hematopoietic cell transplantation (HCT) using posttransplant
cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We …
cyclophosphamide (PTCy) for acute lymphoblastic leukemia (ALL) is being defined. We …
Depletion of exhausted alloreactive T cells enables targeting of stem-like memory T cells to generate tumor-specific immunity
SA Minnie, OG Waltner, KS Ensbey… - Science …, 2022 - science.org
Some hematological malignancies such as multiple myeloma are inherently resistant to
immune-mediated antitumor responses, the cause of which remains unknown. Allogeneic …
immune-mediated antitumor responses, the cause of which remains unknown. Allogeneic …
[HTML][HTML] Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant …
A Esquirol, MJ Pascual, M Kwon, A Pérez… - Bone Marrow …, 2021 - nature.com
Severe infections and their attributable mortality are major complications in recipients of
allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult …
allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult …
[HTML][HTML] Dose intensity for conditioning in allogeneic hematopoietic cell transplantation: can we recommend “when and for whom” in 2021?
N Gagelmann, N Kröger - Haematologica, 2021 - ncbi.nlm.nih.gov
Allogeneic hematopoietic stem-cell transplantation is a potentially curative therapy for
various hematologic diseases. An essential component of this procedure is the pre …
various hematologic diseases. An essential component of this procedure is the pre …
[HTML][HTML] Hematopoietic cell transplantation in the treatment of pediatric acute myelogenous leukemia and myelodysplastic syndromes: guidelines from the American …
K Tarlock, ML Sulis, JH Chewning, JA Pollard… - … and Cellular Therapy, 2022 - Elsevier
The role of allogeneic hematopoietic stem cell transplantation (HCT) in the treatment of
acute myelogenous leukemia (AML) in children is reviewed and critically evaluated in this …
acute myelogenous leukemia (AML) in children is reviewed and critically evaluated in this …
[HTML][HTML] Hematopoietic cell transplantation in the treatment of newly diagnosed adult acute myeloid leukemia: an evidence-based review from the American Society of …
B Dholaria, BN Savani, BK Hamilton, B Oran… - … and Cellular Therapy, 2021 - Elsevier
The role of hematopoietic cell transplantation (HCT) in the management of newly diagnosed
adult acute myeloid leukemia (AML) is reviewed and critically evaluated in this evidence …
adult acute myeloid leukemia (AML) is reviewed and critically evaluated in this evidence …
Longitudinal outcome over two decades of unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: an ALWP/EBMT analysis
Purpose: We evaluated outcomes of unrelated transplantation for primary
refractory/relapsed (ref/rel) acute myeloid leukemia (AML), comparing two cohorts according …
refractory/relapsed (ref/rel) acute myeloid leukemia (AML), comparing two cohorts according …
The infusion of ex vivo, interleukin-15 and-21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients—a randomized trial
KH Lee, SR Yoon, JR Gong, EJ Choi, HS Kim, CJ Park… - Leukemia, 2023 - nature.com
Clinical effect of donor-derived natural killer cell infusion (DNKI) after HLA-haploidentical
hematopoietic cell transplantation (HCT) was evaluated in high-risk myeloid malignancy in …
hematopoietic cell transplantation (HCT) was evaluated in high-risk myeloid malignancy in …